Sector: Healthcare|Industry: Diagnostics & Research|Market Cap: $22.07B|Employees: 7.9K
Waters Corporation is a global leader in analytical instruments and software, specializing in chromatography, mass spectrometry, and thermal analysis. The company's core business model revolves around designing, manufacturing, selling, and servicing these systems, along with related consumables and software. Waters holds a strong market position in the pharmaceutical and life science industries, with a significant geographic presence in over 35 countries.
Total net sales decreased by 1% from $2,971.96 million in 2022 to $2,956.42 million in 2023, primarily due to a 22% reduction in sales in China. This was partially offset by growth in other regions and the acquisition of Wyatt Technology.
Operating income decreased by 6% from $873.39 million in 2022 to $817.68 million in 2023. This decline is attributable to higher salary expenses, severance-related costs, and expenses related to the Wyatt acquisition.
Net income decreased by 9% from $707.76 million in 2022 to $642.23 million in 2023, despite a decrease in the effective tax rate from 15.5% to 12.8%. This indicates that the decrease in operating income had a larger impact than the tax benefit.